These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 24627925

  • 1. Re-evaluation of cases with gastroenteropancreatic neuroendocrine tumors between 2004 and 2012 according to the 2010 criteria.
    Ozkara S, Aker F, Yesil A, Senates E, Canbey C, Yitik A, Gonen C.
    Hepatogastroenterology; 2013 Oct; 60(127):1665-72. PubMed ID: 24627925
    [Abstract] [Full Text] [Related]

  • 2. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
    Nuñez-Valdovinos B, Carmona-Bayonas A, Jimenez-Fonseca P, Capdevila J, Castaño-Pascual Á, Benavent M, Pi Barrio JJ, Teule A, Alonso V, Custodio A, Marazuela M, Segura Á, Beguiristain A, Llanos M, Martinez Del Prado MP, Diaz-Perez JA, Castellano D, Sevilla I, Lopez C, Alonso T, Garcia-Carbonero R.
    Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
    [Abstract] [Full Text] [Related]

  • 3. The importance of clinical information in patients with gastroenteropancreatic neuroendocrine tumor.
    Kudo A, Akashi T, Kumagai J, Ban D, Inokuchi M, Kojima K, Kawano T, Tanaka S, Arii S.
    Hepatogastroenterology; 2012 Apr; 59(120):2450-3. PubMed ID: 22584507
    [Abstract] [Full Text] [Related]

  • 4. Comparison of WHO 2000 and WHO 2010 classifications of gastroenteropancreatic neuroendocrine tumors.
    Karakuş E, Helvacı A, Ekinci O, Dursun A.
    Turk J Gastroenterol; 2014 Feb; 25(1):81-7. PubMed ID: 24918137
    [Abstract] [Full Text] [Related]

  • 5. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
    Pasaoglu E, Dursun N, Ozyalvacli G, Hacihasanoglu E, Behzatoglu K, Calay O.
    Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
    [Abstract] [Full Text] [Related]

  • 6. Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria.
    Farrell JM, Pang JC, Kim GE, Tabatabai ZL.
    Cancer Cytopathol; 2014 Oct; 122(10):770-8. PubMed ID: 25044931
    [Abstract] [Full Text] [Related]

  • 7. Clinical characteristics and prognostic factors of gastroenteropancreatic neuroendocrine tumors: a single center experience in China.
    Hu HK, Ke NW, Li A, Du XJ, Guo Q, Hu WM.
    Hepatogastroenterology; 2015 Oct; 62(137):178-83. PubMed ID: 25911892
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors.
    Hasegawa T, Yamao K, Hijioka S, Bhatia V, Mizuno N, Hara K, Imaoka H, Niwa Y, Tajika M, Kondo S, Tanaka T, Shimizu Y, Kinoshita T, Kohsaki T, Nishimori I, Iwasaki S, Saibara T, Hosoda W, Yatabe Y.
    Endoscopy; 2014 Jan; 46(1):32-8. PubMed ID: 24218309
    [Abstract] [Full Text] [Related]

  • 9. Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods.
    Tang LH, Gonen M, Hedvat C, Modlin IM, Klimstra DS.
    Am J Surg Pathol; 2012 Dec; 36(12):1761-70. PubMed ID: 23026928
    [Abstract] [Full Text] [Related]

  • 10. Plasma chromogranin A levels predict survival and tumor response in patients with advanced gastroenteropancreatic neuroendocrine tumors.
    Chou WC, Chen JS, Hung YS, Hsu JT, Chen TC, Sun CF, Lu CH, Hwang TL.
    Anticancer Res; 2014 Oct; 34(10):5661-9. PubMed ID: 25275071
    [Abstract] [Full Text] [Related]

  • 11. Predictors of long-term outcome in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-octreotate.
    Ezziddin S, Attassi M, Yong-Hing CJ, Ahmadzadehfar H, Willinek W, Grünwald F, Guhlke S, Biersack HJ, Sabet A.
    J Nucl Med; 2014 Feb; 55(2):183-90. PubMed ID: 24434296
    [Abstract] [Full Text] [Related]

  • 12. [Clinicopathologic characteristics of 127 cases of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) studied in an oncology hospital].
    Alvarado-Cabrero I, de Anda-González J, Hernández-Hernández B, Mantilla-Morales A, Valencia-Cedillo R, Medrano-Guzmán R.
    Rev Gastroenterol Mex; 2012 Feb; 77(4):174-80. PubMed ID: 23142406
    [Abstract] [Full Text] [Related]

  • 13. Twenty years of gastroenteropancreatic neuroendocrine tumors: is reclassification worthwhile and feasible?
    Grillo F, Albertelli M, Annunziata F, Boschetti M, Caff A, Pigozzi S, Ferone D, Mastracci L.
    Endocrine; 2016 Jul; 53(1):58-62. PubMed ID: 26362059
    [Abstract] [Full Text] [Related]

  • 14. [Controversies of gastroenteropancreatic neuroendocrine tumor pathology diagnosis].
    Sasano H, Kasajima A.
    Nihon Shokakibyo Gakkai Zasshi; 2014 Dec; 111(12):2280-5. PubMed ID: 25482903
    [No Abstract] [Full Text] [Related]

  • 15. Variability of the Ki-67 proliferation index in gastroenteropancreatic neuroendocrine neoplasms - a single-center retrospective study.
    Shi H, Zhang Q, Han C, Zhen D, Lin R.
    BMC Endocr Disord; 2018 Jul 28; 18(1):51. PubMed ID: 30055596
    [Abstract] [Full Text] [Related]

  • 16. Recent classifications systems for gastroenteropancreatic neuroendocrine tumors A single-center experience.
    Yagmur Y, Söğutcü N, Gümüş S.
    Ann Ital Chir; 2020 Jul 28; 91():598-604. PubMed ID: 32989209
    [Abstract] [Full Text] [Related]

  • 17. Cocoon formation in patients with midgut neuroendocrine tumors: a rare and unrecognized final pathway.
    Wang YZ, King H, Diebold A.
    Pancreas; 2013 Aug 28; 42(6):944-8. PubMed ID: 23587852
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading.
    Sugimoto M, Takagi T, Hikichi T, Suzuki R, Watanabe K, Nakamura J, Kikuchi H, Konno N, Waragai Y, Asama H, Takasumi M, Watanabe H, Obara K, Ohira H.
    World J Gastroenterol; 2015 Jul 14; 21(26):8118-24. PubMed ID: 26185384
    [Abstract] [Full Text] [Related]

  • 19. Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumors.
    Boyar Cetinkaya R, Vatn M, Aabakken L, Bergestuen DS, Thiis-Evensen E.
    Scand J Gastroenterol; 2014 Jun 14; 49(6):734-41. PubMed ID: 24679166
    [Abstract] [Full Text] [Related]

  • 20. Symptomatic presentation as a predictor of recurrence in gastroenteropancreatic neuroendocrine tumors: A single institution experience over 15 years.
    Baptiste GG, Postlewait LM, Ethun CG, Le N, McInnis MR, Russell MC, Winer JH, Kooby DA, Staley CA, Maithel SK, Cardona K.
    J Surg Oncol; 2016 Aug 14; 114(2):163-9. PubMed ID: 27157897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.